Ingavirin 60 mg 7 caps

Products might cost different amounts at a pharmacy and online. The image of the product may differ from the actual product.

Dosage and administration
For a dosage of 60 mg: Inside. Regardless of food intake. For the treatment of influenza and acute respiratory viral infections, children from 7 to 17 years old are prescribed 1 capsule (60 mg) 1 time per day. The duration of treatment is 5-7 days (depending on the severity of the condition). The drug is started from the moment the first symptoms of the disease appear, preferably no later than 2 days from the onset of the disease.
Adults and children with severe symptoms, as well as in the presence of concomitant diseases (diseases of the respiratory and cardiovascular systems, diabetes mellitus, obesity) should take a double dose of the drug in the first three days of the disease, then continue taking the usual dosage for 2-4 days .
For the prevention of influenza and acute respiratory viral infections after contact with sick people, children from 7 to 17 years old are prescribed 1 capsule (60 mg) 1 time per day for 7 days. For a dosage of 90 mg/30 mg: Inside. Regardless of food intake.
In children from 3 to 6 years old who have difficulty swallowing the capsule, dilution of the contents of the capsule in water or apple juice is allowed. To do this, carefully open the capsule over a container with a small amount (50-70 ml) of boiled water or apple juice at room temperature, pour the contents of the capsule into water or juice, mix the mixture for 20 seconds and drink it whole. Adding sugar is allowed. The mixture should be prepared immediately before taking; the finished mixture is not subject to storage.
For the treatment and prevention of influenza and acute respiratory viral infections, adults are prescribed 90 mg 1 time per day, children from 7 years old - 60 mg 1 time per day, children from 3 to 6 years old - 30 mg 1 time per day.
The duration of treatment for influenza and acute respiratory viral infections in adults and children from 7 years old is 5-7 days (depending on the severity of the condition). The duration of treatment for influenza and acute respiratory viral infections in children from 3 to 6 years is 5 days. The drug is started from the moment the first symptoms of the disease appear, preferably no later than 2 days from the onset of the disease.
For the prevention of influenza and acute respiratory viral infections after contact with sick persons, adults and children from 7 years of age, the drug is prescribed for 7 days, for children from 3 to 6 years - for 5 days.
If after 5 days of treatment there is no improvement or the symptoms worsen, or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the method of application and in the doses indicated in the instructions.

For a dosage of 60 mg: hypersensitivity to the active substance or any other component of the drug. Lactase deficiency, lactose intolerance, glucose-galactose malabsorption. Pregnancy. breastfeeding period. Children's age up to 7 years. This dosage form is not intended for use in persons 18 years of age and older (it is necessary to use dosage forms that provide the possibility of taking the drug Ingavirin at a dose of 90 mg).
For a dosage of 90 mg / 30 mg: Individual intolerance to the components of the drug.
Lactase deficiency, lactose intolerance, glucose-galactose malabsorption. Pregnancy. Children under 13 years of age for the indication "treatment of influenza A and B and other acute respiratory viral infections (adenoviral infection, parainfluenza, respiratory syncytial infection)". Children under 18 years of age for the indication "prevention of influenza A and B and other acute respiratory viral infections".
for a dosage of 30 mg / 90 mg: Hypersensitivity to the active substance or any other component of the drug.
Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.
Pregnancy.
breastfeeding period.
Children's age up to 3 years.
Use during pregnancy and during breastfeeding
The use of the drug during pregnancy has not been studied.
The use of the drug during lactation has not been studied, therefore, if necessary, the use of the drug during lactation should stop breastfeeding.

The health is harmed by improper usage! Please carefully read the information in the package booklet or on the packaging!

Discuss the use with your doctor or pharmacist.

Never use it longer than recommended.

Patients with hypersensitivity to the components should NOT use the product.

The customer is responsible for making informed decisions about purchasing and using these products. Any reliance on the information provided herein or the use of products sold on this website is solely at the customer's own risk.
Please read our Healthcare Disclaimer.